Literature DB >> 17592454

The development of quality control standards for radiation therapy equipment in Canada.

Peter Dunscombe1, Harry Johnson, Clement Aresnault, George Mawko, Jean-Pierre Bissonnette, Jan Seuntjens.   

Abstract

Among the essential components of a comprehensive quality assurance program in radiotherapy are the quality control protocols to be used on the equipment and, in particular, the performance objectives and criteria. In the present work, we describe the development of a suite of quality control documents for use across Canada. Following a generic format, we are generating concise, clear standards for the most commonly used equipment in radiotherapy, with the emphasis on performance measures. The final standards of performance are confirmed following cross-country consultation facilitated by the availability of draft documents on the Canadian Medical Physics web site.

Entities:  

Mesh:

Year:  2006        PMID: 17592454      PMCID: PMC5722407          DOI: 10.1120/jacmp.v8i1.2380

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


I. INTRODUCTION

The provision of health care services to Canadians is largely the responsibility of the ten provinces and three territories. Although the services that must be provided free to the population are specified in the federal Canada Health Act, operational and financial aspects of service provision are determined by the provinces and territories. This service delivery structure applies equally to cancer care as it does to other medical services. The Canadian Association of Provincial Cancer Agencies (CAPCA) is a body that meets regularly to discuss issues of common interest to the organizations responsible for the delivery of cancer care in Canada. A proposal recently accepted by CAPCA was to initiate a process aimed at harmonizing quality assurance activities in radiation treatment programs across the country. This initiative has resulted in a draft document titled Standards for Quality Assurance at Canadian Radiation Treatment Centres. (hereinafter Standards). Practical and essential components of any quality assurance program for radiation therapy are the quality control tests carried out on the increasingly sophisticated equipment used in the planning and delivery of treatment. The draft document referred to appendices, which, when developed, would specify the performance standards to be required of equipment used in the preparation and delivery of radiation therapy to all Canadian cancer patients. The development of the quality control standards themselves was, appropriately, delegated to the national professional body representing Canadian radiation oncology physicists: the Canadian Organization of Medical Physicists (COMP). In turn, COMP established a Task Group, the members of which are the authors of the present work, to coordinate the generation of the standards documents. We here describe the philosophy, format, and process adopted by the Task Group, and we refer readers to the web site on which both the approved and draft standards may be reviewed.

II. MATERIALS AND METHODS

A. Documents

The documents upon which the standards are based originated from several sources. Some of the original documents were developed by the Medical Physics Professional Advisory Committee of Cancer Care Ontario and its predecessor, the Ontario Cancer Treatment and Research Foundation. Documents dealing with more recent technology were either specifically commissioned by CAPCA for the purpose of standards development, or, in one case, was based on a recent publication. Also vital to the present project are the many publications relating to quality control and quality assurance in radiotherapy. These include—but are not limited to—recommendations promulgated by the American Association of Physicists in Medicine, The Institute of Physics and Engineering in Medicine, and medical physics compendia.( , )

B. Philosophy and scope

The philosophy behind the development of the Standards documents was that they should focus on the standards themselves and not include descriptions of how the tests are performed. It is assumed that physicists who perform or who supervise the performance of the tests possess an appropriate level of knowledge. Otherwise, the bibliography refers the physicist to the recent literature on the subject. Furthermore, radiation safety has not been specifically included. To do so would require updating the documents each time federal or provincial regulations change, and the Task Group did not feel able to accept this responsibility. However, for completeness, some of the more straightforward tests performed on a daily basis were included. The Standards documents are intended to be brief and unambiguous. Distribution through a web site facilitates updates as experience with new techniques is gained. To maintain focus and unambiguity, a generic document format was adopted, with these sections: Introduction—largely generic Performance Objectives and Criteria—generic System Description—custom Acceptance Tests and Commissioning—largely generic Quality Control of Equipment—largely generic Documentation—generic Table of QC Tests—custom entries in a generic format References and Bibliography—custom

C.1 Performance Objectives and Criteria

The generic Performance Objectives and Criteria section includes six classes: Functionality Reproducibility Accuracy Characterisation and Documentation Data Transfer and Validation Completeness As an example of a generic portion of the documents, Appendix 1 shows the exact wording used in the Performance Objectives and Criteria section. The attempt here, and elsewhere in the generic sections, is to be unambiguous and, where appropriate, prescriptive. The six classes were considered to encompass the range of responses that adequately describe the results of testing. Frequency of testing is also clearly specified, but provides flexibility for operational considerations.

D. Document generation and review

Regardless of whether a source document was commissioned specifically for the development of the Standards or had been generated before this project was initiated, it was sent to a knowledgeable Canadian medical physicist for external review. The reviewer looked at the source document in the light of relevant international recommendations and provided detailed comments on the suggested standards. Two of the authors of the present work were assigned to each document, one as the primary task group reviewer and one as the secondary reviewer. It was the responsibility of these two members of the group to consider the source document, the external reviewer's comments, and the international literature; to recommend the draft standards; and then to prepare the relevant documentation in the format described above. This task has been simplified for the more recent documents, because the generic format had been decided, and standards could be commissioned to be consistent with that format. Once the primary and secondary task group reviewers had agreed on their version of the standard, that standard was circulated to whole Task Group for approval. Following this final internal step, the standard was posted on www.medphys.ca for consideration by the Canadian medical physics community at large. During the next phase, which is ongoing, the comments from physicists “in the field” are being solicited and considered. Comments are fed back into the internal review process, and the standard is modified if required. Comments received so far have ranged from technical to language to typographical. Once the Task Group has reviewed, incorporated, and approved suggested changes, the standards undergo one final formal review by the Canadian Organization of Medical Physicists before national adoption. So far, the national review process has been completed for the first six standards.

III. RESULTS

At the time of writing, standards documents for the following equipment have been approved by COMP: Linear accelerators Conventional simulators Orthovoltage units Cobalt units Multileaf collimators Electronic portal imaging devices The following draft standards have been posted and are currently under national review: Remote afterloading brachytherapy equipment Major dosimetry equipment CT simulators Prostate brachytherapy equipment SRS/T equipment. Tables 1–6 show the six currently approved standards and illustrate the generic format adopted. Notes (not shown for space reasons) accompany each table to clarify the meaning of numerical tolerances and action levels, but these notes do not recommend measurement techniques.
Table 1

Quality control tests for medical linear accelerators (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Daily
DL1Door interlock/last person outFunctional
DL2Motion interlockFunctional
DL3Couch brakesFunctional
DL4Beam status indicatorsFunctional
DL5Patient audiovisual monitorsFunctional
DL6Room radiation monitorsFunctional
DL7Beam interrupt/countersFunctional
DL8Lasers/crosswires12
DL9Optical distance indicator12
DL10Optical back pointer23
DL11Field size indicator12
DL12Output constancy—photons2%3%
DL13Dynamic wedge factors1%2%
DL14Output constancy—electrons2%3%
Monthly
ML1Emergency offFunctional
ML2Wedge, tray cone interlocksFunctional
ML3Accessories integrity and centeringFunctional
ML4Gantry angle readouts0.5°
ML5Collimator angle readouts0.5°
ML6Couch position readouts12
ML7Couch isocenter12
ML8Couch angle0.5°
ML9Optical distance indicator12
ML10Crosswire centering12
ML11Light/radiation coincidence12
ML12Field size indicator12
ML13Relative dosimetry1%2%
ML14Central axis depth dose reproducibility1 (2%)2 (3%)
ML15Beam flatness2%3%
ML16Beam symmetry2%3%
ML17RecordsComplete
Annually
AL1Reference dosimetry—TG511%2%
AL2Relative output factor reproducibility1%2%
AL3Wedge transmission factor reproducibility1%2%
AL4Accessory transmission factor reproducibility1%2%
AL5Output reproducibility vs. gantry angle1%2%
AL6Beam symmetry reproducibility vs. gantry angle2%3%
AL7Monitor chamber linearity1%2%
AL8End monitor effect0.1 MU0.2 MU
AL9Collimator rotation isocenter12
AL10Gantry rotation isocenter12
AL11Couch rotation isocenter12
AL12Coincidence of collimator, gantry, couch axes12
AL13Coincidence of isocenters12
AL14Couch deflection35
AL15Independent quality control reviewComplete
Table 6

Quality control tests for electronic portal imaging devices (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Daily
DE1Mechanical integrityFunctional
DE2Electrical integrityFunctional
DE3Collision interlocksFunctional
DE4Image qualityReproducibility
Monthly
ME1Positioning in the imaging plane12
ME2Positioning perpendicular to the imaging plane1020
ME3Image qualityReproducibility
ME4ArtifactsReproducibility
ME5Spatial distortion12
ME6Monitor controlsReproducibility
ME7RecordsComplete
Six monthly
SE1Spatial resolutionReproducibility
SE2NoiseReproducibility
SE3On‐screen measurement tools0.51
SE4Setup verification tools0.5 (0.5°)1 (1°)
Annually
AE1Independent quality control reviewComplete
Standards currently under development include those for Data management systems Treatment planning systems Intensity‐modulated radiation therapy Quality control tests for medical linear accelerators (tolerances and action levels are specified in millimeters unless otherwise stated) Quality control tests for conventional simulators (tolerances and action levels are specified in millimeters unless otherwise stated) Quality control tests for kilovoltage radiotherapy units (tolerances and action levels are specified in millimeters unless otherwise stated) Quality control tests for teletherapy units (tolerances and action levels are specified in millimeters unless otherwise stated) Quality control tests for multileaf collimators (tolerances and action levels are specified in millimeters unless otherwise stated) May not apply to all designs. Quality control tests for electronic portal imaging devices (tolerances and action levels are specified in millimeters unless otherwise stated) These latter standards will be posted as they become available. The interested reader is directed to www.medphys.ca to review the complete results of the project to date.

IV. DISCUSSION AND CONCLUSIONS

This project has achieved its objectives to date. The largely generic format of the Standards has aided clarity of interpretation and expedited development of the documents—particularly the later documents, which could be composed to fit the format. At some stage in the future, if it is deemed desirable, all the available documents could easily be consolidated into one because so much of the content is generic. Posting the drafts on an easily accessible web site facilitates feedback and constitutes a method for obtaining a national consensus on the standards. The medical physics community can consider not only the objectives and criteria of the tests, but also the resource implications of adopting the standards. Furthermore, standards approved at this time may easily be updated as new knowledge and equipment become available. Updates can be disseminated almost instantaneously. The structure of health care delivery in Canada is not conducive to the development of nationally legislated quality control standards, and such legislation is unlikely to be passed in this case. However, once approved and adopted, the standards discussed here may well form an easily monitored component of licensing and accreditation activities applied to cancer treatment facilities.
Table 2

Quality control tests for conventional simulators (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Daily
DS1Door interlockFunctional
DS2Motion interlockFunctional
DS3Beam status indicatorsFunctional
DS4Emergency off buttonsFunctional
DS5Collision avoidanceFunctional
DS6Lasers/crosswires12
DS7Optical distance indicator12
DS8Crosswires/reticle/block tray12
DS9Light/radiation coincidence12
DS10Field size indicators12
Monthly
MS1Gantry angle readouts0.5°
MS2Collimator angle readouts0.5°
MS3Couch position readouts12
MS4Alignment of FAD movement12
MS5Couch isocenter23
MS6Couch parallelism12
MS7Laser/crosswire isocentricity12
MS8Optical distance indicator12
MS9Crosswire centering12
MS10Light/radiation coincidence12
MS11Field size indicators12
MS12RecordsComplete
Six‐monthly
SS1Lead apronFunctional
SS2 kVp 5%10%
SS3Reference dosimetry5%10%
SS4Beam quality (HVL)5%10%
SS5Automatic exposure control5%10%
SS6Focal spotReproducible
SS7ContrastReproducible
SS8ResolutionReproducible
SS9Fluoroscopic timer5%10%
Annually
AS1Redefine isocenter12
AS2Couch deflection35
AS3Alignment of focal spots0.51
AS4Independent quality control reviewComplete
Table 3

Quality control tests for kilovoltage radiotherapy units (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Daily
DK1Patient monitoring audiovisual devicesFunctional
DK2Door closing mechanism and interlockFunctional
DK3Couch movement and brakesFunctional
DK4Unit motions and motion stopsFunctional
DK5Interlocks for added filters/kV‐filter choiceFunctional
DK6Beam status indicatorsFunctional
DK7Beam‐off at key‐off testFunctional
DK8Emergency off testFunctional
DK9kV and mA indicatorsFunctional
DK10Backup timer/monitor unit channel check1%2%
DK11Dosimetric test: output check3%5%
Monthly
MK1Mechanical stability and safetyFunctional
MK2Cone selection and competencyFunctional
MK3Physical distance indicators23
MK4Accuracy of head tilt and rotation readouts1.5°
MK5Light/x‐ray field coincidence23
MK6Light field size23
MK7X‐ray field size indicator23
MK8X‐ray field uniformity/filter integrity5%8%
MK9Timer and end effect errorCharacterize ±0.05 min
MK10Output linearity1%
MK11Output reproducibilityCharacterize<.03 CoV
MK12Beam quality10%15%
MK13Output calibration verification2%3%
MK14Timer accuracy verification2%3%
MK15RecordsComplete
Annually
AK1Reference dosimetry1%2%
AK2Alignment of focal spots0.51
AK3kVp measurement5%10%
AK4Focal spot sizeReproducible
AK5Independent quality control reviewComplete
Table 4

Quality control tests for teletherapy units (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Daily
DCO1Door interlock/last person outFunctional
DCO2Motion interlockFunctional
DCO3Couch brakesFunctional
DCO4Beam status indicatorsFunctional
DCO5Patient audiovisual monitorsFunctional
DCO6Room radiation monitorsFunctional
DCO7Emergency offFunctional
DCO8Beam interrupt/countersFunctional
DCO9Head swivel lockFunctional
DCO10Lasers/crosswires12
DCO11Optical distance indicator12
DCO12Optical back pointer23
DCO13Field size indicator12
Monthly
MCO1Latching of wedges, traysFunctional
MCO2Wedge interlocksFunctional
MCO3Gantry angle readouts0.5°
MCO4Collimator angle readouts0.5°
MCO5Couch position readouts12
MCO6Couch rotation isocenter23
MCO7Optical distance indicator12
MCO8Crosswire centering12
MCO9Light/Radiation coincidence23
MCO10Field size indicator12
MCO11Relative dosimetry1%2%
MCO12Shutter errorReproducible
MCO13Beam symmetry (source position)2%3%
MCO14RecordsComplete
Annually
ACO1Reference dosimetry1%2%
ACO2Relative output factor reproducibility1%2%
ACO3Central axis depth dose reproducibility1%2%
ACO4Wedge transmission factor reproducibility1%2%
ACO5Accessory transmission factor reproducibility1%2%
ACO6Output reproducibility vs. gantry angle1%2%
ACO7Beam symmetry reproducibility vs. gantry angle2%3%
ACO8Timer linearity1%2%
ACO9Shutter error0.03 min.0.05 min.
ACO10Collimator rotation isocenter23
ACO11Gantry rotation isocenter23
ACO12Couch rotation isocenter23
ACO13Coincidence of collimator, gantry, couch axes23
ACO14Coincidence of isocenters23
ACO15Couch deflection35
ACO16Independent quality control reviewComplete
Table 5

Quality control tests for multileaf collimators (tolerances and action levels are specified in millimeters unless otherwise stated)

DesignatorTestPerformance
ToleranceAction
Patient‐specific
PM1Verification of transferred data vs. printed template12
PM2Daily verification of correct dataReproducibility
PM3Verification of record and verify programmingReproducibility
Monthly
MM1Digitizer check (if used)Functional
MM2Light and radiation field coincidence12
MM3Leaf positions for standard field template12
MM4Electron field interlocksFunctional
MM5 a Leaf alignment1
MM6RecordsComplete
Yearly
AM1Leaf transmission (all energies)Reproducibility
AM2Leakage between leaves (all energies)Reproducibility
AM3 a Transmission through abutting leavesReproducibility
AM4Stability with gantry rotationReproducibility
AM5Alignment with jaws1
AM6Independent quality control reviewComplete

May not apply to all designs.

  1 in total

1.  Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40.

Authors:  G J Kutcher; L Coia; M Gillin; W F Hanson; S Leibel; R J Morton; J R Palta; J A Purdy; L E Reinstein; G K Svensson
Journal:  Med Phys       Date:  1994-04       Impact factor: 4.071

  1 in total
  5 in total

1.  Angular dependence of the output of a kilovoltage X-ray therapy unit.

Authors:  Mehran Goharian; Ian Nygren; Mauro Tambasco; Jose Eduardo Villarreal Barajas
Journal:  J Appl Clin Med Phys       Date:  2010-06-09       Impact factor: 2.102

2.  Production, review, and impact of technical quality control guidelines in a national context.

Authors:  Michelle K Nielsen; Kyle E Malkoske; Erika Brown; Kevin Diamond; Normand Frenière; John Grant; Natalie Pomerleau-Dalcourt; Jason Schella; L John Schreiner; Laurent Tantôt; J Eduardo Villareal-Barajas; Jean-Pierre Bissonnette
Journal:  J Appl Clin Med Phys       Date:  2016-11-08       Impact factor: 2.102

3.  COMP report: CPQR technical quality control guidelines for radiation treatment centers.

Authors:  Kyle E Malkoske; Michelle K Nielsen; Laurent Tantôt; Natalie Pomerleau-Dalcourt; Marie-Pierre Milette; Kevin R Diamond; Normand Frenière; Marie-Joëlle Bertrand; J Eduardo Villarreal-Barajas; David K Sasaki; Jason Schella; John Grant; L John Schreiner; Jean-Pierre Bissonnette
Journal:  J Appl Clin Med Phys       Date:  2018-02-26       Impact factor: 2.102

4.  COMP report: CPQR technical quality control guidelines for treatment planning systems.

Authors:  Jose E Villarreal-Barajas
Journal:  J Appl Clin Med Phys       Date:  2018-01-27       Impact factor: 2.102

5.  COMP report: CPQR technical quality control guidelines for low-dose-rate permanent seed brachytherapy.

Authors:  Luc Beaulieu; Dee-Ann Radford; J Eduardo Villarreal-Barajas
Journal:  J Appl Clin Med Phys       Date:  2018-03-14       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.